MCID: CRV069
MIFTS: 32

Cervix Disease malady

Categories: Reproductive diseases

Aliases & Classifications for Cervix Disease

Aliases & Descriptions for Cervix Disease:

Name: Cervix Disease 12 14
Uterine Cervical Diseases 42
Cervix Disorders 41
Cervix Diseases 69

Classifications:



External Ids:

Disease Ontology 12 DOID:2253
MeSH 42 D002577
NCIt 47 C40241
UMLS 69 C0007867

Summaries for Cervix Disease

MedlinePlus : 41 the cervix is the lower part of the uterus, the place where a baby grows during pregnancy. the cervix has a small opening that expands during childbirth. it also allows menstrual blood to leave a woman's body. your health care provider may perform a pap test during your health checkup to look for changes to the cells of the cervix, including cervical cancer. other problems with the cervix include: cervicitis - inflammation of the cervix. this is usually from an infection. cervical incompetence - this can happen during pregnancy. the opening of the cervix widens long before the baby is due. cervical polyps and cysts - abnormal growths on the cervix

MalaCards based summary : Cervix Disease, also known as uterine cervical diseases, is related to cervical incompetence and cervical polyp, and has symptoms including pelvic pain An important gene associated with Cervix Disease is MT-TG (Mitochondrially Encoded TRNA Glycine). The drugs Azithromycin and Doxycycline have been mentioned in the context of this disorder. Affiliated tissues include cervix, uterus and testes.

Wikipedia : 71 The cervix or cervix uteri (Latin: neck of the uterus) is the lower part of the uterus in the human... more...

Related Diseases for Cervix Disease

Diseases related to Cervix Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 104)
id Related Disease Score Top Affiliating Genes
1 cervical incompetence 10.7
2 cervical polyp 10.7
3 benign mediastinal neurilemmoma 10.2 CD79A FLNA
4 alcoholic neuropathy 10.2 CD40LG CD79A
5 camptodactyly vertebral fusion 10.2 CD40LG CD79A
6 spinal polio 10.2 CD40LG CD79A
7 acrofacial dysostosis 10.2 FLNA MRAP
8 rabies 10.2 CD40LG CD79A
9 unilateral retinoblastoma 10.2 CD40LG CD79A
10 delta chain disease 10.2 CD40LG CD79A
11 discitis 10.2 CD40LG CD79A
12 spinal canal and spinal cord meningioma 10.2 CD40LG CD79A
13 trichostrongyloidiasis 10.2 CD40LG CD79A
14 colloid adenoma 10.2 CD40LG CD79A
15 heart septal defect 10.2 CD40LG CD79A
16 cutaneous polyarteritis nodosa 10.2 CD40LG CD79A
17 mild pre-eclampsia 10.2 CD40LG CD79A
18 retinal microaneurysm 10.2 CD40LG CD79A
19 pediatric meningioma 10.2 CD40LG CD79A
20 tonsil cancer 10.2 CD40LG CD79A
21 indomethacin antenatal infection 10.2 CD40LG CD79A
22 postcricoid region cancer 10.2 CD40LG CD79A
23 beach ear 10.2 CD40LG CD79A
24 acute kidney tubular necrosis 10.2 CD40LG CD79A
25 atheroembolism of kidney 10.2 CD40LG CD79A
26 partial sensory epilepsy 10.2 CD40LG CD79A
27 diabetic angiopathy 10.2 CD40LG CD79A
28 endocarditis 10.2 CD40LG CD79A
29 muscular dystrophy 10.2 CD40LG CD79A
30 dumping syndrome 10.2 CD40LG CD79A
31 striatonigral degeneration 10.2 CD40LG CD79A
32 ciliary body spindle cell melanoma 10.2 CD40LG CD79A
33 oculoauricular syndrome 10.2 CD40LG MT-TG
34 purulent endophthalmitis 10.2 CD40LG CD79A
35 mu chain disease 10.2 CD40LG CD79A
36 generalized atherosclerosis 10.2 CD40LG CD79A
37 bursitis 10.2 CD40LG CD79A
38 syphilis 10.2 CD40LG CD79A
39 homocystinuria 10.2 CD40LG CD79A
40 mental retardation, autosomal dominant 19 10.2 CD40LG CD79A
41 hemangioma of orbit 10.2 CD40LG CD79A
42 diabetic peripheral angiopathy 10.2 CD40LG MRAP
43 leiomyosarcoma 10.2 CD40LG CD79A
44 childhood electroclinical syndrome 10.2 CXCL8 SERPINH1
45 immunoglobulin beta deficiency 10.2 CD40LG CD79A
46 gestational diabetes 10.2 CD40LG CD79A
47 angiolipoma 10.2 CD40LG MRAP
48 odontogenic myxoma 10.2 CD40LG CD79A
49 fallopian tube carcinoma 10.2 CD79A CXCL8
50 chronic mucocutaneous candidiasis 10.2 CD40LG CD79A

Graphical network of the top 20 diseases related to Cervix Disease:



Diseases related to Cervix Disease

Symptoms & Phenotypes for Cervix Disease

UMLS symptoms related to Cervix Disease:


pelvic pain

Drugs & Therapeutics for Cervix Disease

Drugs for Cervix Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 526)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 53477736 447043
2
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2 564-25-0 54671203
3
Lymecycline Approved Phase 4 992-21-2 5280963
4
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
5
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 137-58-6 3676
6
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
7
Misoprostol Approved Phase 4,Phase 3,Phase 2 59122-46-2 5282381
8
Oxytocin Approved, Vet_approved Phase 4,Phase 3,Phase 1 50-56-6 439302 53477758
9
Povidone-iodine Approved Phase 4,Phase 3 25655-41-8
10
Nicotine Approved Phase 4 54-11-5 942 89594
11
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
12
Mepivacaine Approved, Vet_approved Phase 4 96-88-8 4062
13
Isosorbide Dinitrate Approved Phase 4 87-33-2 6883
14
Nitric Oxide Approved Phase 4 10102-43-9 145068
15
Dinoprostone Approved Phase 4,Phase 3,Phase 2 363-24-6 5280360
16
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
17
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 1 22916-47-8 4189
18
Iron Approved Phase 4,Phase 3,Phase 1,Phase 2 7439-89-6 23925
19
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3 437-38-7 3345
20 Dienogest Approved Phase 4,Phase 2 65928-58-7
21
Levonorgestrel Approved, Investigational Phase 4,Phase 1,Phase 2 797-63-7, 17489-40-6 13109
22
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
23
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
24
Chloroprocaine Approved Phase 4 133-16-4 8612
25
Procaine Approved, Investigational, Vet_approved Phase 4 59-46-1 4914
26
Nandrolone Approved, Experimental, Illicit Phase 4 434-22-0, 62-90-8 9904 229455
27
Nandrolone decanoate Approved, Illicit Phase 4 360-70-3 9677
28
Vitamin C Approved, Nutraceutical Phase 4,Phase 2 50-81-7 5785 54670067
29
Enclomiphene Investigational Phase 4 15690-57-0
30 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
31 Liver Extracts Phase 4,Phase 3,Phase 2,Phase 1
32 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
33 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
34 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
35 Antimalarials Phase 4,Phase 2,Phase 1
36 Antiparasitic Agents Phase 4,Phase 2,Phase 3,Phase 1
37 Antiprotozoal Agents Phase 4,Phase 2,Phase 3,Phase 1
38 Anesthetics Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
39 Anesthetics, Local Phase 4,Phase 3,Phase 2,Phase 1
40 Anti-Arrhythmia Agents Phase 4,Phase 3,Phase 2
41 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
42 Diuretics, Potassium Sparing Phase 4,Phase 3,Phase 2
43 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
44 Sodium Channel Blockers Phase 4,Phase 3,Phase 2
45 Neurotransmitter Agents Phase 4,Phase 3,Phase 2
46 Epoetin alfa Phase 4,Phase 3 113427-24-0
47 Hematinics Phase 4,Phase 3,Phase 2,Phase 1
48 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1
49 Estrogens Phase 4,Phase 3,Phase 2,Phase 1
50 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 1261)
id Name Status NCT ID Phase
1 Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China Unknown status NCT01021904 Phase 4
2 Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? Unknown status NCT01101750 Phase 4
3 Can Alternative Treatment Have an Impact on Cervical Dysplasia? Unknown status NCT00842738 Phase 4
4 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4
5 Prophylactic Lidocaine Spray for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Second Trimester Dilatation and Evacuation Unknown status NCT02097017 Phase 4
6 Influence of Gum Chewing on Postoperative Bowel Activity After Complete Staging Surgery for Gynecological Malignancies Unknown status NCT01835119 Phase 4
7 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
8 Alternate Dosing Schedules Study for HPV Vaccine (ADS) Completed NCT02280642 Phase 4
9 Alternate Dosing Schedules Study for HPV Vaccine Completed NCT00862810 Phase 4
10 Comparing the Rate of Insufficient Cells for Diagnosis Between Surepath® and Conventional Smear in Women After Radiation Therapy for Cervical Cancer Completed NCT01988376 Phase 4
11 Effect of HPV Vaccination on Women Aged 25 Years Completed NCT02296255 Phase 4
12 Patient Navigation in the Safety Net:CONNECTeDD Completed NCT00613275 Phase 4
13 Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls Completed NCT01173900 Phase 4
14 Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking Completed NCT00365508 Phase 4
15 Epoetin Beta in Treating Anemia in Patients With Cervical Cancer Completed NCT00046969 Phase 4
16 Management of Cervical Intraepithelial Neoplasia Grade 2 Completed NCT00733109 Phase 4
17 V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) Completed NCT01544478 Phase 4
18 Role of Intrauterine Cornual Block in Combination With Direct Cervical Block in Outpatient Endometrial Ablation Completed NCT01808898 Phase 4
19 Effect of Hormone Replacement Therapy on Lupus Activity Completed NCT00392093 Phase 4
20 Optimal Balloon Catheter Placement During Sonohysterography Completed NCT01936116 Phase 4
21 Medical Management of Late Intrauterine Death. Completed NCT02488642 Phase 4
22 24-Hour Vaginal Dinoprostone Pessary Versus Gel for Labour Induction Completed NCT00843362 Phase 4
23 Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment Completed NCT01372904 Phase 4
24 Does Preoperative Vaginal Preparation With Povidone-iodine Before Cesarean Delivery Reduce the Risk of Endometritis? Completed NCT01437228 Phase 4
25 The Effect of Nutritional Counseling for Cancer Patients Completed NCT01962272 Phase 4
26 Induction of Labor With a Foley Balloon Catheter: Inflation With 30ml Compared to 60ml Completed NCT00451308 Phase 4
27 Tenaculum Pain Control Study Completed NCT01421641 Phase 4
28 Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial Atrophy Completed NCT02144987 Phase 4
29 Tolerability and Satisfaction With Evie Completed NCT01969812 Phase 4
30 Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac Completed NCT01710189 Phase 4
31 Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina Completed NCT00194324 Phase 4
32 A Study of Korean Society of Spine Surgery on the Outcomes of Anterior Cervical Discectomy and Fusion Recruiting NCT01911013 Phase 4
33 Cerclage vs Cervical Pessary in Women With Cervical Incompetence Recruiting NCT02405455 Phase 4
34 Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. Recruiting NCT01953107 Phase 4
35 Comparing Health Services Interventions for the Prevention of HPV-related Cancer Recruiting NCT02837926 Phase 4
36 Comparison Between D&C and Hysteroscopy in Management of AUB in Perimenopausal Women Recruiting NCT02705222 Phase 4
37 Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction Recruiting NCT02902653 Phase 4
38 Comparison of Two Embryo Transfer Catheters in Patients Undergoing in Vitro Fertilization and Embryo Transfer Recruiting NCT02024880 Phase 4
39 Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial Recruiting NCT02639429 Phase 4
40 Intracervical Lidocaine Versus Intramuscular Diclofenac for Pain Relief in HSG in a Tertiary Hospital in Kano Recruiting NCT02918812 Phase 4
41 Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study Recruiting NCT01824537 Phase 4
42 CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening (CITRUS Study) Active, not recruiting NCT01895517 Phase 4
43 Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India Active, not recruiting NCT00923702 Phase 4
44 Ohio Patient Navigator Research Program Active, not recruiting NCT01569672 Phase 4
45 The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Active, not recruiting NCT02629510 Phase 4
46 Effectiveness of Cervical Screening in HPV Vaccinated Women Enrolling by invitation NCT02149030 Phase 4
47 Chloroprocaine Spinal Anesthesia for Cervical Cerclage (CP Spinal) Not yet recruiting NCT02862912 Phase 4
48 Scientific Evaluation of One or Two Doses of the Bivalent or Nonavalent Prophylactic HPV Vaccines Not yet recruiting NCT03180034 Phase 4
49 HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions Not yet recruiting NCT03051516 Phase 4
50 Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women Not yet recruiting NCT02440750 Phase 4

Search NIH Clinical Center for Cervix Disease

Cochrane evidence based reviews: uterine cervical diseases

Genetic Tests for Cervix Disease

Anatomical Context for Cervix Disease

MalaCards organs/tissues related to Cervix Disease:

39
Cervix, Uterus, Testes

Publications for Cervix Disease

Variations for Cervix Disease

Expression for Cervix Disease

Search GEO for disease gene expression data for Cervix Disease.

Pathways for Cervix Disease

GO Terms for Cervix Disease

Biological processes related to Cervix Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 B cell proliferation GO:0042100 9.16 CD40LG CD79A
2 protein localization to cell surface GO:0034394 8.96 FLNA MRAP
3 platelet activation GO:0030168 8.8 CD40LG FLNA GP6

Sources for Cervix Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....